The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open‐Label Trial of Linezolid versus Ampicillin‐Sulbactam/Amoxicillin‐Clavulanate
Abstract
Foot infections in diabetic patients are predominantly caused by gram-positive cocci, many of which are now antibiotic resistant. Because linezolid is active against these pathogens, we compared the efficacy and safety of intravenous and oral formulations with that of intravenous ampicillin-sulbactam and intravenous and oral amoxicillin-clavulanate given for 7-28 days in a randomized, open-label, multicenter study of all types of foot infection in diabetic patients (ratio of linezolid to comparator drug recipients, 2:1). Among 371 patients, the clinical cure rates associated with linezolid and the comparators were statistically equivalent overall (81% vs. 71%, respectively) but were significantly higher for linezolid-treated patients with infected foot ulcers (81% vs. 68%; P=.018) and for patients without osteomyelitis (87% vs. 72%; P=.003). Cure rates were comparable for inpatients and outpatients and for both oral and intravenous formulations. Drug-related adverse events were significantly more common in the linezolid group, but they were generally mild and reversible. Linezolid was at least as effective as aminopenicillin/beta-lactamase inhibitors for treating foot infections in diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oral Clindamycin and Ciprofloxacin Therapy for Diabetic Foot Infections
Sesin, G. P., Paszko, A., & O'Keefe, E. M. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02563.x · Cited by 20
RetractedReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Stevens, D. L., Herr, D., Lampiris, H., Hunt, J. L., Batts, D. H., Hafkin, B., & the Linezolid MRSA Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/340353 · Cited by 506
Self-citationIn vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
Zurenko, G. E., Yagi, B. H., Schaadt, R. D., Allison, J. W., Kilburn, J. O., Glickman, S. E., Hutchinson, D. K., Barbachyn, M. R., & Brickner, S. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.839 · Cited by 461
Rubinstein, E., Cammarata, S. K., Oliphant, T. H., Wunderink, R. G., & the Linezolid Nosocomial Pneumonia Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/318486 · Cited by 440
Self-citationOsteomyelitis of the Foot in Diabetic Patients
Lipsky, B. A. (1997) · Clinical Infectious Diseases · doi:10.1086/516148 · Cited by 362
Self-citationMethicillin‐resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem
Dang, C. N., Prasad, Y. D. M., Boulton, A. J. M., & Jude, E. B. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00860.x · Cited by 292
Outpatient Management of Uncomplicated Lower-Extremity Infections in Diabetic Patients
Lipsky, B. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.4.790 · Cited by 253
Self-citationStevens, D. L., Smith, L. G., Bruss, J. B., McConnell-Martin, M. A., Duvall, S. E., Todd, W. M., & Hafkin, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3408-3413.2000 · Cited by 242
Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic
Tentolouris, N., Jude, E. B., Smirnof, I., Knowles, E. A., & Boulton, A. J. M. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00132.x · Cited by 216
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Lew, D. P., & Waldvogel, F. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16727-5 · Cited by 1,883
Lipsky, B. A., Berendt, A. R., Cornia, P. B., Pile, J. C., Peters, E. J. G., Armstrong, D. G., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis346 · Cited by 1,766
Self-citationDiagnosis and Treatment of Diabetic Foot Infections
Lipsky, B. A., Berendt, A. R., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., LeFrock, J. L., Lew, D. P., Mader, J. T., Norden, C., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/424846 · Cited by 1,146
Self-citationDiabetic Foot Disorders: A Clinical Practice Guideline (2006 Revision)
Frykberg, R. G., Zgonis, T., Armstrong, D. G., Driver, V. R., Giurini, J. M., Kravitz, S. R., Landsman, A. S., Lavery, L. A., Moore, J. C., Schuberth, J. M., et al. (2006) · The Journal of Foot and Ankle Surgery · doi:10.1016/s1067-2516(07)60001-5 · Cited by 831
Metadata
- Authors
- Lipsky, B. A., Itani, K., Norden, C., & the Linezolid Diabetic Foot Infections Study Group
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01
- Volume
- 38
- Issue
- 1
- Pages
- 17-24
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2037186376
- Cited by
- 311
- References
- 22
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open‐Label Trial of Linezolid versus Ampicillin‐Sulbactam/Amoxicillin‐Clavulanate. https://app.cochat.ai/papers/10.1086/380449
- The paper
- Lipsky, B. A., Itani, K., Norden, C., & the Linezolid Diabetic Foot Infections Study Group. (2004). Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open‐Label Trial of Linezolid versus Ampicillin‐Sulbactam/Amoxicillin‐Clavulanate. Clinical Infectious Diseases. https://doi.org/10.1086/380449
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.